𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemia

✍ Scribed by J C. Ferrer-García; J. Pérez-Silvestre; I. Martínez-Mir; A. Herrera-Ballester


Publisher
Springer
Year
2006
Tongue
English
Weight
73 KB
Volume
43
Category
Article
ISSN
0940-5429

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Perceived symptoms of hypoglycaemia in e
✍ A.J. Jaap; G.C. Jones; R.J. McCrimmon; I.J. Deary; B.M. Frier 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

Elderly insulin-treated diabetic patients have a high risk of severe hypoglycaemia, yet their hypoglycaemic symptom profile has attracted little research. In this study, the frequency and intensity of symptoms of hypoglycaemia were recorded using a validated questionnaire in 132 insulin-treated diab

Lower incidence of severe hypoglycaemia
✍ Andreas Holstein; Armin Plaschke; Eick-Hartwig Egberts 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract ## Background Severe hypoglycaemia is a potentially life‐threatening condition. The aim of the present study was to compare the frequency of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. ## Methods This prospective, population‐ba

Reversal of increased lymphocyte PC-1 ac
✍ Vladisav Stefanović; Slobodan Antić; Marina Mitić-Zlatković; Predrag Vlahović 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Background: The plasma cell differentiation antigen (pc-1) is an inhibitor of insulin receptor tyrosine kinase activity, and has been implicated in the pathogenesis of insulin resistance in type 2 diabetes. metformin increases peripheral insulin sensitivity and, therefore, we have studied the ef